<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02836717</url>
  </required_header>
  <id_info>
    <org_study_id>SGChir201601</org_study_id>
    <nct_id>NCT02836717</nct_id>
  </id_info>
  <brief_title>Long Term Efficacy of Sacral Nerve Modulation (SNM) in Patients With Constipation or Stool Incontinence</brief_title>
  <official_title>Long Term Efficacy of Sacral Nerve Modulation (SNM) in Patients With Constipation or Stool Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cantonal Hospital of St. Gallen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cantonal Hospital of St. Gallen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine the success rate, the success duration, the
      complication rate, maintenance effort and quality of life several years after sacral nerve
      modulation (SNM) treatment for constipation or stool incontinence.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2016</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>subjective complaint reduction</measure>
    <time_frame>10 years</time_frame>
    <description>Treatment is considered a success if patients report a subjective 50% reduction in disease related complaints</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of permanent stimulator implantations</measure>
    <time_frame>1 month</time_frame>
    <description>Rate of patients who finish the test phase with an external stimulator successfully (subjective reporting and 50% reduction of Wexner score for incontinence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication rate</measure>
    <time_frame>10 years</time_frame>
    <description>rate of treatment related complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of reoperations</measure>
    <time_frame>10 years</time_frame>
    <description>rate of reoperations necessary due to the treatment (e.g. electrode dislocation, electrode breakage)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maintenance cost</measure>
    <time_frame>10 years</time_frame>
    <description>Cost incurred to maintain the treatment (e.g. relocation of electrodes, replacement of stimulator due to failure or low battery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal incontinence quality of life (FIQL)</measure>
    <time_frame>10 years</time_frame>
    <description>Rockwood's FIQL scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wexner Score</measure>
    <time_frame>10 years</time_frame>
    <description>Wexner score for fecal incontinence</description>
  </secondary_outcome>
  <enrollment type="Actual">101</enrollment>
  <condition>Constipation</condition>
  <condition>Fecal Incontinence</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sacral nerve modulation</intervention_name>
    <description>electric stimulation of the sacral nerve using an implanted electrode and stimulator</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients starting an SNM treatment for constipation or fecal incontinence between March
        2006 and October 2015
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who had received an SNM treatment in the last 10 years

        Exclusion Criteria:

          -  pudendal nerve stimulation

          -  refusal to allow use of clinical data for retrospective data analysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lukas Marti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cantonal Hospital St. Gallen</affiliation>
  </overall_official>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2016</study_first_submitted>
  <study_first_submitted_qc>July 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 19, 2016</study_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cantonal Hospital of St. Gallen</investigator_affiliation>
    <investigator_full_name>Lukas Marti</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>sacral nerve modulation</keyword>
  <keyword>quality of life</keyword>
  <keyword>stimulator maintenance</keyword>
  <keyword>SNM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
    <mesh_term>Fecal Incontinence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

